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Infectious bursal disease (IBD), also known as the Gumboro disease, has been a great 
concern for poultry industry worldwide. The first outbreak of IBD due to very virulent (vv) 
IBD virus (IBDV) infection in Malaysia was reported in 1991. The major economic impact of 
the disease is high mortality and poor performance. The virus causes immunosuppression 
where if the infected chicken recovered from the acute disease, they become more susceptible 
to infections of other pathogens and fail to respond to vaccines. Therefore, prevention is 
important and vaccination has become the principal control measure of IBDV infection in 
chickens. The conventional attenuated live and killed vaccines are the most commonly used 
vaccines. With the advancement of knowledge and technology, new generation of 
genetically-engineered vaccines like viral vector and immune complex vaccines have been 
commercialised. Moreover, hatchery vaccination is becoming a common practise, in addition 
to farm vaccination. Currently, the disease is considerably under controlled with the 
introduction of vaccination. However, occasional field outbreaks are still commonly reported. 
The demand for vaccines that could suit the field situation continues to exist. The endemicity 
of disease, presence of challenge in the farm and maternally derived antibody in chicks are 
affecting the choice vaccine as well as the vaccine development and vaccination strategies. In 
this review, advances made in various vaccines that have been commercialised or under 
development, and challenges that they face, are outlined. Furthermore, how the emergence of 
vvIBDV affect the progress of vaccine development and influence its vaccination strategy are 
discussed. 
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